2024-05-19
2024-05-19
November 21, 2024
Summary | |
---|---|
Cancer Type | Lymphoma |
Grade | IIB |
Stage | T4N2M0,IIIb |
Ethnicity | Asian |
Gender | M |
Age | 72 |
Pathology Diagnosis | Gastric cancer, tumor mass: 8cm x 7cm, inflammatory cells infiltrated through body and gastric antrum, Small tumor foci are remained, consistent with the changes after chemotherapy. Regional LN: right cardial LN (0/5), left cardial LN (0/7), LN of vasa brevia (0/2), left gastroepiploic vascular LN (0/2), right gastroepiploic vascular LN (0/1), inferior pyloric LN (0/1), LN of left gastric artery (0/3), LN of hepatic artery in ligamentum hepatoduodenale(0/1). IHC results: CD44(+), Cmet(weak +), EGFR(+), HER2(3+), Ki-67(+50-75%), MMP7(-), P170(-), P27(+50-75%), P53(+>75%), TOPOII(-). |
Biopsy Site | NA |
Treatment History | NA |
Pathology QC | EBV+ lymphoma; Large cell poorly differentiated malignant tumor, accord with anaplastic large cell lymphoma (P3) |
Special Features | Slight BW loss; revival take rate is low |
Mouse Strain | NOD SCID |
TMA | NA |
Viral Status in PDX | EBV+ (P3, RNAseq) |
Available In | CB_CN |
RNA Seq | P3 |
Exome Seq | P3 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy